Decreased frequency of HLA-DRB1(*)13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix

International Journal of Cancer

Volumn 69, Issue 3, 1996, Pages 159-164

  Sastre Garau, Xavier ^a   Loste, Marie Noelle ^b   Vincent Salomon, Anne ^a   Favre, Michel ^c   Mouret, Emmanuelle ^a   De la Rochefordiere, Anne ^a   Durand, Jean Claude ^a   Tartour, Eric ^a   Lepage, Virginia ^b   Charron, Dominique ^b  

^a INSTITUT CURIE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FRANCE; GENE FREQUENCY; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADULT; AGE FACTORS; ALLELES; FEMALE; FRANCE; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 0004668405     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960621)69:3<159::AID-IJC1>3.0.CO;2-Z     Document Type: Article

References (30)

1. APPLE, R.J., BECKER, T., WHEELER, C.M. and ERLICH, H.A., Comparison of human leukocyte antigen DR-DQ disease association found with cervical dysplasia and invasive cervical carcinoma. J. nat. Cancer Inst., 87, 427-435 (1995).
2. APPLE, R.J., ERLICH, H.A., KLITZ, W., MANOS, M., BECKER, T. and WHEELER, C., HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet., 6, 157-162 (1994).
3. BUYSE, I., DECORTE, R., BAENS, M., CUPPENS, H., SEMANA, G., EDMONDS, M.P., MARYNEN, P. and CASSIMAN, J.J., Rapid DNA typing of class-II HLA antigens using the polymerase chain reaction and reverse dot-blot hybridization. Tiss. Antigens, 41, 1-14 (1993).
4. CAILLAT-ZUCMAN, S., GARCHON, H.J., TIMSIT, J., ASSAN, R., BOITARD, C., DJILALI-SAIAH, I., BOUGNÈRES, P. and BACH, J.F., Age-dependent HLA genetic heterogeneity of type-1 insulin-dependent diabetes mellitus. Clin. Invest., 90, 2242-2250 (1992).
5. CHEN, L., THOMAS, E.K., HU, S., HELLSTRÖM, I. and HELLTRÖM, K.E., Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc. nat. Acad. Sci. (Wash.), 88, 110-114 (1991).
6. COLEMAN, N. and STANLEY, M.A., Analysis of HLA-DR expression on keratinocytes in cervical neoplasia. Int. J. Cancer, 56, 314-319 (1994).
7. CROMME, F.V., AIREY, J., HEEMELS, M-T., PLOEGH, H.L., KEATING, P.J., STERN, P.L., MEIJER, C.J. and WALBOOMERS, J.M., Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. exp. Med., 179, 335-340 (1994).
8. DE VRIES, R.R.P., HLA and disease: from epidemiology to immunotherapy. Europ. J. clin. Invest., 22, 1-8 (1992).
9. ELLIS, J.R.M., KEATING, P.J., BAIRD, J., HOUNSELL, E.F., RENOUF, D.V., ROWE, M., HOPKINS, D., DUGGAN-KEEN, M.F., BARTHOLOMEW, J.S., YOUNG, L.S. and STERN, P.L., The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature Med., 1, 464-470 (1995).
10. FENTON, J., CHEVRET, S., ASSELAIN, B., DE LA ROCHEFORDIÈRE, A., MATHIEU, G., LABIB, A., DURAND, J.C. and SALMON, R.J., Le cancer invasif du col utérin chez la femme jeune: étude rétrospective de 236 cas. Bull. Cancer, 77, 109-116 (1990).
11. GLEW, S., DUOGAN-KEEN, M., CABRERA, T. and STERN, P., HLA Class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res., 52, 4009-4016 (1992).
12. GLEW, S., DUOGAN-KEEN, M., GHOSH, A., IVINSON, A., SINNOTT, P., DAVIDSON, J., DYER, P. and STERN, P., Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum. Immunol., 37, 157-164 (1993).
13. HAN, R., BREITBURD, F., MARCHE, P. and ORTH, G., Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class-II genes. Nature (Lond.), 356, 66-68 (1992).
14. HELLAND, A., BORRESEN, A.L., KAERN, J., RONNINGEN, K.S. and THORBSY, E., HLA antigens and cervical carcinoma. Nature (Lond.), 356, 23 (1992).
15. HILL, A.V.S., ALLSOPP, C., KWIATKOWSKI, D., ANSTEY, N.M., TWUMASI, P., ROWE, P.A., BENNETT, S., BREWSTER, D., MCMICHAEL, A.J. and GREENWOOD, B.M., Common West African HLA antigens are associated with protection from severe malaria. Nature (Lond.), 352, 595-600 (1991).
16. IMANISHI, T., AKAZA, T., KIMURA, A., TOKUNAGA, K. and GOJOBORI, T., Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: K. Tsuji, M. Aizawa and T. Sasaki (eds.), HLA 91. Proceedings of Eleventh International Histocompatibility Workshop and Conference. Vol. 1, Oxford University Press, London (1992).
17. KIMURA, A. and SASAZUKI, T., Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA typing technique. In: K. Tsuji, M. Aisawa and T. Sasaki (eds.), HLA 1991, pp. 397-419, Oxford University Press, London (1992).
18. LORINCZ, A.T., REID, R., JENSON, B., GREENBERG, M., LANCASTER, W. and KURMAN, R., Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol, 79, 328-337 (1992).
19. MALEJCZYK, J., MALEJCZYK, M., URBANSKI, A., KÖCK, A., JABLONSKA, S., ORTH, G. and LUGER, T., Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: a mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells. Cell. Immunol., 136, 155-164 (1991).
20. MCGUIRE, W., HILL, A.V.S., ALLSOPP, C.E.M., GREENWOOD, B.M. and KWIATKOWSKI, D., Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (Lond.), 371, 508-510 (1994).
21. OLSDONE, M.B.A., Molecular anatomy of viral persistence. J. Virol., 65, 6381-6386 (1991).
22. ORTH, G., FAVRE, M., BREIDBURD, F., CROISSANT, O., JABLONSKA, S., OBALEK, S., JARZABEK-CHORZELSKA, M. and RZESA, G., Epidermodysplasia verruciformis. A model to understand the role of papillomaviruses in human cancer. In: M. Essex et al. (eds.), Viruses in naturally occuring cancers, pp. 259-282, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1980).
23. OSTÖR, A., Natural history of cervical intraepithelial neoplasia. Int. J. gynecol. Pathol., 12, 186-192 (1993).
24. RUTLEDGE, F.N., MITCHELL, M.F., MUNSELL, M., BASS, S., MCGUF- FEE, V. and ATKINSON, E.N., Youth as a pronostic factor in carcinoma of the cervix: a matched analysis. Gynecol. Oncol., 44, 123-130 (1992).
25. TAIT, B.D., HARRISON, L.C., DRUMMOND, B.P., STEWART, V., VARNEY, M. and HONEYMAN, M.C., HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum. Immunol., 42, 116-122 (1995).
26. TARTOUR, E., GEY, A., SASTRE-GARAU, X., PANNETIER, C., MOSSERI, V., KOURILSKY, P. and FRIDMAN, W.H., Analysis of Interleukin-6 gene expression in cervical neoplasia using a quantitative polymerase reaction assay: evidence for enhanced Interleukin-6 gene expression in invasive carcinoma. Cancer Res., 54, 6243-6248 (1994).
27. THURSZ, M., KWIATKOWSKI, D., ALLSOPP, C., GREENWOOD, B., THOMAS, H. and HILL, A., Association between an MHC class-II allele and clearance of hepatitis B virus in the Gambia. New Engl. J. Med., 332, 1065-1069 (1995).
28. WANK, R., TER MEULEN, J., LUANDE, J., EBERHARDT, H.C. and PAWLITA, M., Cervical intraepithelial neoplasia, cervical carcinoma, and risk of patients with HLA-DQB1* 0602, *301, *0303 alleles. Lancet, 341, 1215 (1993).
29. WANK, R. and THOMSSEN, C., High risk of squamous-cell carcinoma of the cervix for women with HLA-DQ3. Nature (Lond.), 352, 723-725 (1991).
30. ZUR HAUSEN, H. and DE VILLIERS, E.M., Human papillomaviruses. Ann. Rev. Microbiol., 48, 427-447 (1994).